Skip to content

Author's details

Reviewer's details

Other Oncological Emergencies

Background

In sub-Saharan Africa, oncological emergencies like vomiting and anaphylactic reactions are significant challenges due to limited healthcare infrastructure. 

Chemotherapy-induced vomiting is common due to the aggressive treatment regimens and the often late-stage diagnosis of cancers, which exacerbates patients’ vulnerability. However, access to antiemetic drugs is limited, making management difficult.

Anaphylactic reactions, often triggered by chemotherapy or biologic agents, are also concerning. The lack of immediate access to life-saving interventions like epinephrine, coupled with delays in reaching healthcare facilities, increases the risk of fatal outcomes.

Resource constraints and healthcare worker shortages further complicate the management of these emergencies. Addressing these requires improved access to medications, training, and timely care.

Discussion
Vomiting

Chemotherapy induced nausea and vomiting is one of the most common acute and distressing side effect of cancer treatment. It can result in serious fluid and electrolytede rangement.

CLASSIFICATION

  • Acute; within the first 24hrs after chemotherapy
  • Delayed; occurs more than 24hrs
  • Anticipatory; occurs before a new cycle of chemotherapy in response to conditioned stimuli such as the smell, site or sound of treatment room. This usually occurs at V3-4 cycles.
  • Chronic; in patients with advanced cancer. The cause is not well known but can be due to gastrointestinal, cranial, metabolic, drug induced e.g. morphine, cytotoxic chemo induced or radiation induced.

 

Prevention

• Centrally acting antiemetics e.g. ondansetron @0.15mg/kg/dose IV 30 mins before chemo may be repeated 4-8hrly

• Corticosteroids- dexamethason

TREATMENT

• Antiemetics.

• Correction of fluid and electrolyte imbalances.

Anaphylaxis Reaction

It is one of the most catastrophic potential side effects of biologic and chemotherapy. May occur in oncology patients who are exposed to bacterial products such as L-asparaginase, or cytotoxic agents e.g paclitaxel. Any drug can lead to hyperimmune response resulting in anaphylaxis.

  

Clinical Features

Angioedema and urticaria are the most common manifestations of anaphylaxis and make up >90% of allergic reactions to drugs.

Abdominal pain, chest tightness, upper airway obstruction, bronchospasm and hypotension. Laryngeal edema followed by hypotension is the most frequent cause of death related to allergic reactions.

 

Management
  • Use of ABC in resuscitation.
  • Withdraw the offending drug
  • Epinephrine
  • Steroids
  • Anti histamine

 

 

Prevention Oncologic Emergencies
  1. General Health Promotion: Use health education
  2. Specific Protection
    1. Use of Allopurinol/ Rasburicase at diagnosis
    2. Hyperhydration prior to commencement of Chemotherapy
    3. Optimize haematological parameters before therapy
  3. Early diagnosis and prompt treatment
  4. Limitation of disability
  • RRT
  1. Rehabilitation

 

 

Challenges of Managing Oncologic Emergencies
  • Lack of basic supportive care
  • Lack of blood products
  • Lack of supportive care eg limited Icu spaces
  • Lack of proper nursing care
  • Lack of isolation wards to ensure reverse isolation
  • Lack of trained man power in oncology care
  • Need to establish a standard oncology unit with all required subspecialities
  • Poverty – delay in presentation, poor nutrition
  • Iilliteracy – poor health seeking attitude
Conclusion

Emergencies may arise at diagnosis, as a consequence of therapy, or at time of progression. It is important to anticipate and have high index of suspicion for oncologic emergencies. Careful history and physical examination. Prompt intervention can prevent long term complications. Management can and has improved survival of children with malignancies.

Interesting patient case

A 7-year-old boy undergoing chemotherapy for acute lymphoblastic leukemia (ALL) experienced a severe allergic reaction (anaphylaxis) after receiving the drug asparaginase. He developed difficulty breathing, swelling, and a rash shortly after the infusion. The medical team quickly treated him with epinephrine and oxygen, stabilizing his condition. The boy was monitored in the ICU and later switched to a safer chemotherapy regimen. His family was informed about allergy signs and provided with an emergency epinephrine injector for home use.

Further readings
  1. Nelson’s textbook of pediatrics 21st edition by Kleigman, Behrman, Jenson and Stanton 
  2. Principles and practice of pediatric oncology 4th edition by Philip.A. Pizzo and David.G. Poplack
  3. Williams Haematology,6th edition,by Ernest Beutler M.D,etal.
  4. Zinner SH. Changing epidemiology of infections in    patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis.1999;29(3):490–4. 
  5. Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia.  Acad Emerg Med. 2010;17(2):163–7. 
  6. Moon JM, Chun BJ. Predicting the complicated neutropenic fever in the emergency department.      Emerg Med J. 2009;26(11):802–6.
  7. Roland T. Skeel- Handbook of cancer chemotherapy
  8. Rheingold & Lange, “Oncologic Emergencies”, in Principles & Practice of Pediatric Oncology, eds Pizzo, Poplack. 
  9. Nazemi Emerg Med Clin N Am 27 (2009) 477–495

Author's details

Reviewer's details

Other Oncological Emergencies

In sub-Saharan Africa, oncological emergencies like vomiting and anaphylactic reactions are significant challenges due to limited healthcare infrastructure. 

Chemotherapy-induced vomiting is common due to the aggressive treatment regimens and the often late-stage diagnosis of cancers, which exacerbates patients’ vulnerability. However, access to antiemetic drugs is limited, making management difficult.

Anaphylactic reactions, often triggered by chemotherapy or biologic agents, are also concerning. The lack of immediate access to life-saving interventions like epinephrine, coupled with delays in reaching healthcare facilities, increases the risk of fatal outcomes.

Resource constraints and healthcare worker shortages further complicate the management of these emergencies. Addressing these requires improved access to medications, training, and timely care.

  1. Nelson’s textbook of pediatrics 21st edition by Kleigman, Behrman, Jenson and Stanton 
  2. Principles and practice of pediatric oncology 4th edition by Philip.A. Pizzo and David.G. Poplack
  3. Williams Haematology,6th edition,by Ernest Beutler M.D,etal.
  4. Zinner SH. Changing epidemiology of infections in    patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis.1999;29(3):490–4. 
  5. Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia.  Acad Emerg Med. 2010;17(2):163–7. 
  6. Moon JM, Chun BJ. Predicting the complicated neutropenic fever in the emergency department.      Emerg Med J. 2009;26(11):802–6.
  7. Roland T. Skeel- Handbook of cancer chemotherapy
  8. Rheingold & Lange, “Oncologic Emergencies”, in Principles & Practice of Pediatric Oncology, eds Pizzo, Poplack. 
  9. Nazemi Emerg Med Clin N Am 27 (2009) 477–495

Content

Author's details

Reviewer's details

Other Oncological Emergencies

In sub-Saharan Africa, oncological emergencies like vomiting and anaphylactic reactions are significant challenges due to limited healthcare infrastructure. 

Chemotherapy-induced vomiting is common due to the aggressive treatment regimens and the often late-stage diagnosis of cancers, which exacerbates patients’ vulnerability. However, access to antiemetic drugs is limited, making management difficult.

Anaphylactic reactions, often triggered by chemotherapy or biologic agents, are also concerning. The lack of immediate access to life-saving interventions like epinephrine, coupled with delays in reaching healthcare facilities, increases the risk of fatal outcomes.

Resource constraints and healthcare worker shortages further complicate the management of these emergencies. Addressing these requires improved access to medications, training, and timely care.

  1. Nelson’s textbook of pediatrics 21st edition by Kleigman, Behrman, Jenson and Stanton 
  2. Principles and practice of pediatric oncology 4th edition by Philip.A. Pizzo and David.G. Poplack
  3. Williams Haematology,6th edition,by Ernest Beutler M.D,etal.
  4. Zinner SH. Changing epidemiology of infections in    patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis.1999;29(3):490–4. 
  5. Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia.  Acad Emerg Med. 2010;17(2):163–7. 
  6. Moon JM, Chun BJ. Predicting the complicated neutropenic fever in the emergency department.      Emerg Med J. 2009;26(11):802–6.
  7. Roland T. Skeel- Handbook of cancer chemotherapy
  8. Rheingold & Lange, “Oncologic Emergencies”, in Principles & Practice of Pediatric Oncology, eds Pizzo, Poplack. 
  9. Nazemi Emerg Med Clin N Am 27 (2009) 477–495
Advertisement